Stefan S Bielack
Overview
Explore the profile of Stefan S Bielack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
4732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bielack S, Soussain C, Fox C, Houillier C, Murciano T, Osborne W, et al.
J Cancer Res Clin Oncol
. 2024 Oct;
150(10):441.
PMID: 39356310
High-dose methotrexate (HDMTX) is used in the treatment of a range of adult and childhood cancers. Although HDMTX can provide effective anti-tumor activity with an acceptable safety profile for most...
2.
Bielack S, Mettmann V, Hecker-Nolting S, Borkhardt A, Hardes J, Kager L, et al.
Pediatr Blood Cancer
. 2024 Sep;
71(12):e31344.
PMID: 39344062
Background: Osteosarcoma may arise as a secondary malignancy following rhabdomyosarcoma (RMS). We utilized the Cooperative Osteosarcoma Study Group (COSS) database to better understand this association. Patients And Methods: The COSS...
3.
Fernandes J, Blattmann C, Hecker-Nolting S, Kager L, Kevric M, Mettmann V, et al.
Cancer Med
. 2024 Aug;
13(1):e6893.
PMID: 39102672
Purpose: Prognostic factors have been well described for osteosarcoma, but analyses evaluating the further course of long-term survivors are lacking. We used the large database of the Cooperative Osteosarcoma Study...
4.
Green D, Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3395-3406.
PMID: 38869831
Osteosarcoma and Ewing sarcoma are bone tumors mostly diagnosed in children, adolescents, and young adults. Despite multimodal therapy, morbidity is high and survival rates remain low, especially in the metastatic...
5.
Bielack S, Mettmann V, Baumhoer D, Blattmann C, Burkhardt B, Deinzer C, et al.
Cancers (Basel)
. 2024 May;
16(10).
PMID: 38791915
Purpose: Osteosarcoma may arise as a secondary cancer following leukemias or lymphomas. We intended to increase the knowledge about such rare events. Patients And Methods: We searched the Cooperative Osteosarcoma...
6.
Mettmann V, Blattmann C, Friedel G, Harrabi S, von Kalle T, Kager L, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254767
Background: To evaluate patient and tumour characteristics, treatment, and their impact on survival in patients with multi-systemic metastases at initial diagnosis of high-grade osteosarcoma. Precedure: Eighty-three consecutive patients who presented...
7.
Bielack S, Blattmann C, Hassenpflug W, Kager L, Kuhne T, Kevric M, et al.
Anticancer Res
. 2023 Nov;
43(11):4975-4981.
PMID: 37909999
Background/aim: Ewing sarcoma can arise in patients after osteosarcoma or vice versa. Our aim was to learn more about which patients develop these secondary tumors, which treatments may be effective,...
8.
Das A, Fernandez N, Levine A, Bianchi V, Stengs L, Chung J, et al.
Cancer Discov
. 2023 Oct;
14(2):258-273.
PMID: 37823831
Significance: Hypermutant RRD-HGG are susceptible to checkpoint inhibitors beyond initial progression, leading to improved survival when reirradiation and synergistic immune/targeted agents are added. This is driven by their unique biological...
9.
Bielack S, Kempf-Bielack B, Delling G, Exner G, Flege S, Helmke K, et al.
J Clin Oncol
. 2023 Sep;
41(27):4323-4337.
PMID: 37713812
Purpose: To define prognostic factors for response and long-term outcome for a wide spectrum of osteosarcomas, extending well beyond those of the typical young patient with seemingly localized extremity disease....
10.
Mettmann V, Baumhoer D, Bielack S, Blattmann C, Friedel G, von Kalle T, et al.
Cancer Med
. 2023 Aug;
12(17):18219-18234.
PMID: 37548393
Background: To evaluate patient and tumour characteristics, treatment and their impact on survival in patients with a solitary pulmonary metastasis at first relapse of high-grade osteosarcoma. Procedure: Two-hundred and nineteen...